Publication:
Impact of contrast enhanced MRI on lymphocyte DNA damage and serum visfatin level

Simple item page
dc.contributor.authorYildiz, Sema
dc.contributor.authorCece, Hasan
dc.contributor.authorKaya, Ihsan
dc.contributor.authorCelik, Hakim
dc.contributor.authorTaskin, Abdullah
dc.contributor.authorAksoy, Nurten
dc.contributor.authorKocyigit, ABDÜRRAHİM
dc.contributor.authorEren, Mehmet A.
dc.contributor.institutionauthorKOÇYİĞİT, ABDÜRRAHİM
dc.date.accessioned2020-10-29T17:15:44Z
dc.date.available2020-10-29T17:15:44Z
dc.date.issued2011-08-01T00:00:00Z
dc.description.abstractObjectives: Nephrogenic systemic fibrosis is a novel clinical entity encountered in subjects undergoing contrast enhanced magnetic resonance imaging (MRI). The aim of the present study is to evaluate the impact of contrast enhanced MRI exposure on lymphocyte DNA damage and serum levels of visfatin.
dc.identifier.citationYildiz S., Cece H., Kaya I., Celik H., Taskin A., Aksoy N., Kocyigit A., Eren M. A. , -Impact of contrast enhanced MRI on lymphocyte DNA damage and serum visfatin level-, CLINICAL BIOCHEMISTRY, cilt.44, ss.975-979, 2011
dc.identifier.doi10.1016/j.clinbiochem.2011.05.005
dc.identifier.scopus79960324406
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25627
dc.identifier.wosWOS:000293043400007
dc.titleImpact of contrast enhanced MRI on lymphocyte DNA damage and serum visfatin level
dc.typeArticle
dspace.entity.typePublication
local.avesis.id38ffcef0-9b52-43cb-bfd7-bdffa101bdff
local.publication.isinternational1
relation.isAuthorOfPublication75babbd2-f46b-4121-aa00-54d883a6f907
relation.isAuthorOfPublication.latestForDiscovery75babbd2-f46b-4121-aa00-54d883a6f907
Files
Collections
Silinecekler